NCT03569436View on ClinicalTrials.gov

Effectiveness and Safety of Nivolumab in Participants That Have Head and Neck Cancer That Has Come Back or Has Spread

CompletedOBSERVATIONAL
Enrollment

262

Participants

Timeline

Start Date

February 14, 2018

Primary Completion Date

June 26, 2020

Study Completion Date

June 26, 2020

Conditions
Cancer of Head and NeckCancer of the HeadCancer of the Neck
Trial Locations (1)

1070052

Local Institution, Tokyo

Sponsors

Collaborators (1)

Ono Pharma USA Inc
All Listed Sponsors
collaborator

Ono Pharma USA Inc

INDUSTRY

lead

Bristol-Myers Squibb

INDUSTRY

NCT03569436 - Effectiveness and Safety of Nivolumab in Participants That Have Head and Neck Cancer That Has Come Back or Has Spread | Biotech Hunter | Biotech Hunter